Skip to main content

Novel 1,3-Diketone Modified Fullerenes for Organic Photovoltaic Cells

Buy Article:

$113.00 plus tax (Refund Policy)

The feasibility of novel 1,3-diketone modified C60s (compound 1 and 2) was studied as acceptor materials in organic photovoltaic cells (OPVC). 1,3-Diketone modified fullerenes were synthesized by the addition reaction of 1,3-bis(5′-hexylthiophen-2′-yl)propane-1,3-dione with C60 in the presence of DBU (1,8-diazabicyclo[5,4,0]undec-7-ene). From this procedure two products can be prepared, which are mono- (1) and di-substituted compound (2) in the yield of 40% and 17%, respectively. OPVCs fabricated by using the mixture of P3HT and compound 1 as an active layer showed excellent power conversion efficiency of about 3.42% after annealed at 160 °C for 15 min and we believe that substantial improvements can be realized by nano-structured heterojunction. It was demonstrated that 1,3-diketone modified C60 (compound 1) was one of the promising candidates for acceptor materials for OPVCs.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Keywords: 1,3-DIKETONE; ACCEPTOR; C60; FULLERENE; N-TYPE; OPVC; ORGANIC PHOTOVOLTAIC CELLS; ORGANIC SEMICONDUCTOR; ORGANIC SOLAR CELLS

Document Type: Research Article

Publication date: 2008-09-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more